Stock listing

NASDAQ:FEED ENvue Medical, Inc. Stock

Home listing (NASDAQ) of ENvue Medical, Inc.

Follow ENvue Medical, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:FEED

$0.223 USD -0.033 (-12.7%)

Close on Nov 20, 2026

Past year -99.5% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$0.215 – $0.230 USDNov 20, 2026
Volume
128 sharesNov 20, 2026
Market cap
—Left out: price × shares is far from the company's reported size
52-week range
$0.121 – $73.080 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$77,503 USDMedian day 7,300 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
ENvue Medical, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:FEED · Home$0.223 USD-0.033 (-12.7%)128$0.230$0.230$0.215$0.255Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:FEED · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.223-0.033-12.7%$0.230$0.230$0.215128
$0.2550.0000.0%$0.255$0.255$0.2551
$0.255+0.005+2.0%$0.255$0.255$0.255100
$0.250+0.008+3.2%$0.250$0.250$0.250100
$0.242-0.018-6.8%$0.390$0.390$0.242102
$0.260-0.003-1.1%$0.263$0.400$0.195103,255
$0.263-0.017-6.1%$0.398$0.398$0.26314,699
$0.280-0.025-8.3%$0.300$0.300$0.21213,745
$0.305-0.037-10.8%$0.260$0.400$0.2604,165
$0.342+0.082+31.5%$0.342$0.342$0.342400
$0.2600.0000.0%$0.260$0.260$0.260700
$0.260-0.090-25.7%$0.203$0.399$0.2036,800
$0.350+0.100+40.0%$0.203$0.350$0.2031,000
$0.250+0.028+12.6%$0.232$0.300$0.20348,700
$0.222+0.002+0.9%$0.222$0.222$0.222800
$0.220-0.030-12.0%$0.232$0.262$0.2207,400
$0.2500.0000.0%$0.250$0.400$0.25013,800
$0.2500.0000.0%$0.220$0.250$0.220700
$0.250+0.068+37.4%$0.182$0.480$0.12134,600
$0.182-0.185-50.4%$0.360$0.360$0.16299,681
$0.367+0.015+4.3%$0.282$0.370$0.2821,200
$0.352-0.148-29.6%$0.300$0.370$0.3004,800
$0.5000.0000.0%$0.510$0.510$0.5005,100
$0.500+0.129+34.8%$0.540$0.540$0.3854,100
$0.371-0.119-24.3%$0.400$0.580$0.3712,800
$0.490-0.020-3.9%$0.352$0.525$0.3523,200
$0.510-0.040-7.3%$0.500$0.550$0.35021,000
$0.550+0.199+56.7%$0.360$0.550$0.3033,500
$0.351+0.001+0.3%$0.350$0.525$0.25550,800
$0.350-0.050-12.5%$0.400$0.400$0.3224,000
$0.400-0.030-7.0%$0.270$0.600$0.27021,000
$0.430+0.030+7.5%$0.300$0.430$0.26013,796
$0.400+0.160+66.7%$0.250$0.400$0.2509,900
$0.240-0.200-45.5%$0.200$0.240$0.2003,900
$0.440-0.010-2.2%$0.450$0.450$0.2305,300
$0.450+0.143+46.6%$0.280$0.450$0.2804,100
$0.307-0.068-18.1%$0.362$0.400$0.2674,800
$0.375-0.057-13.2%$0.431$0.550$0.2987,300
$0.432+0.027+6.7%$0.410$0.550$0.38211,700
$0.405-0.085-17.3%$0.649$0.649$0.40510,600
$0.490-0.110-18.3%$0.500$0.630$0.40010,700
$0.600+0.050+9.1%$0.550$0.600$0.55023,000
$0.550-0.115-17.3%$0.640$0.680$0.36532,400
$0.665-0.080-10.7%$0.660$0.789$0.66014,000
$0.745+0.085+12.9%$0.660$0.790$0.66018,300
$0.660-0.140-17.5%$0.770$0.794$0.65036,201
$0.800-0.230-22.3%$0.850$0.990$0.660125,183
$1.030-2.320-69.3%$3.340$3.420$0.8401,222,300
$3.350-0.230-6.4%$3.600$3.600$3.33021,900
$3.580+0.010+0.3%$3.630$3.680$3.54011,014
$3.570-0.070-1.9%$3.590$3.863$3.500108,449
$3.640-0.640-15.0%$4.100$4.100$3.600148,700
$4.280+0.250+6.2%$4.040$4.620$3.900357,600
$4.030+0.200+5.2%$4.000$4.100$3.90032,400
$3.830-0.280-6.8%$4.160$4.180$3.77025,300
$4.110-0.200-4.6%$4.260$4.270$4.04926,600
$4.310+0.110+2.6%$4.420$4.420$3.870111,300
$4.200+0.060+1.4%$4.200$4.608$4.0922,764
$4.140-0.276-6.3%$4.008$4.200$3.9363,231
$4.416-0.120-2.6%$4.668$4.764$4.416601
$4.536-0.084-1.8%$4.644$4.920$4.536615
$4.620-0.120-2.5%$4.560$4.920$4.560502
$4.740+0.048+1.0%$4.680$4.872$4.4761,290
$4.692-0.132-2.7%$4.848$4.980$4.692340
$4.824-0.264-5.2%$4.920$5.160$4.5841,088

Splits

4 splits since 2023 · NASDAQ:FEED · every price before a split is adjusted for it

DayRatioWhat
1-for-12Consolidation
1-for-10Consolidation
1-for-11Consolidation
1-for-20Consolidation
Ticker
NASDAQ:FEED
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All ENvue Medical, Inc. news

ENvue Medical, Inc. on 6ix

Sector
Health care
Industry
Medical devices & supplies
News releases
28 in the last 12 months · 29 in all · newest Sep 15, 2026 · oldest 2025

Where ENvue Medical, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:FEED · Home listing · This pageNASDAQUnited StatesUSD
BOATS:FEEDBOATSUnited StatesUSD
gettex:56R1gettexGermanyEUR
Frankfurt:56R1FrankfurtGermanyEUR
Munich:56R1MunichGermanyEUR
Lang & Schwarz:A41DDHLang & SchwarzGermanyEUR
LS Exchange:A41DDHLS ExchangeGermanyEUR

Valuation

Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
No market cap
P/E
No market cap
EV/sales
No market cap
EV/EBITDA
No market cap
Price/book
No market cap
Gross margin
−26.1%
Operating margin
Revenue too small
Net margin
Revenue too small
Debt to equity
0.0×
Beta vs S&P 500
0.34

Team and board

Officers

OfficerRole
Doron BesserChief Executive Officer and Director
Nicole Fernandez-McGovernCFO
Anat HofshiVP Clinical Affairs & Product
Marc WaldmanVP Commercial
Rita SilberbergSenior VP & Chief Accounting Officer
Tom DoldVP QA/RA
Zenya GorlikVP R&D
Fred ReuningChief Marketing Officer

Board

DirectorRole
David JohnsonChairman of the Board
Alison Geiger BurgettDirector
Doron BesserChief Executive Officer and Director
Lior BuchmanDirector
Zeev RotsteinDirector
Zvi JosephDirector

Events

QuarterResultsShare move
Q2 2026Aug 17, 2026−1.6%
Q1 2026May 29, 2026−2.4%
Q4 2025Feb 25, 2026−14.4%
Q3 2025Nov 14, 2025−5.1%
Q2 2025Aug 19, 2025−15.1%
Q1 2025May 20, 2025−9.2%
Q4 2024Mar 31, 2025−19.1%
Q3 2024Nov 29, 2024−3.1%
Q2 2024Aug 20, 2024+3.6%
Q1 2024May 14, 2024−1.1%
All 20 quarters
QuarterResultsShare move
Q4 2023Feb 28, 2024−2.9%
Q3 2023Nov 14, 2023+16.7%
Q2 2023Aug 15, 2023−17.7%
Q1 2023May 16, 2023−0.6%
Q4 2022Mar 1, 2023−3.3%
Q3 2022Nov 14, 2022−3.2%
Q2 2022Aug 16, 2022−22.1%
Q1 2022May 17, 2022+6.9%
Q4 2021Mar 2, 2022+3.8%
Q3 2021Nov 16, 2021−10.4%

Open Events

Financings

RaiseDate
Equity line of credit (ELOC) facility
Announced: up to US$50M
Use of proceeds: Advance its next-generation technology platform and evaluate selective strategic acquisition and business development opportunities
Aug 12, 2026

Open Financings · Read by 6ix AI from the company's releases

IPO

Withdrawn on Feb 9, 2015. Filed with the SEC to go public on Feb 6, 2014, as Nano Vibronix, Inc.

Units offered
1,500,000 units
Underwriters' option
Up to 225,000 more units
Listing
NVBXU on the Nasdaq Capital Market · Has applied to list

Steps

StepWhen
Draft sent to the SEC in confidenceNov 12, 2013
Filed publiclyFeb 6, 2014
Amended 11 timesNewest Jul 21, 2014
Filing withdrawnFeb 9, 2015

Open IPO · From the cover of the amended prospectus (S-1/A) filed Jul 21, 2014

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue2.55M2.56M2.28M752.0K1.70M623.0K530.0K318.0K239.0K229.0K
Cost of revenue2.40M1.05M746.0K585.0K925.0K409.0K249.0K158.0K88.0K88.0K
Gross profit153.0K1.51M1.54M167.0K770.0K214.0K281.0K160.0K151.0K141.0K
Research and development1.76M909.0K185.0K283.0K293.0K171.0K514.0K614.0K693.0K584.0K
Operating income-22.9M-3.58M-3.44M-5.01M-5.68M-4.72M-5.15M-4.30M-3.09M-2.32M
Depreciation and amortization897.0K1.00K1.00K1.00K2.00K2.00K4.00K6.00K5.00K7.00K
EBITDA-22.0M-3.58M-3.44M-5.01M-5.68M-4.72M-5.15M-4.30M-3.09M-2.31M
Interest expense135.0K135.0K347.0K147.0K15.0K37.0K0
Income before tax-18.5M-3.69M-3.68M-5.41M-14.3M-4.31M-5.81M-4.28M-4.93M-2.71M
Income tax-307.0K19.0K29.0K35.0K32.0K15.0K-17.0K-127.0K38.0K117.0K
Net income-18.2M-3.71M-3.71M-5.45M-14.3M-4.33M-5.79M-4.15M-4.96M-2.83M
Earnings per share, basic-26.69-137.30-23.32-3.84-11.35-0.42-0.83-0.64-1.17-0.62
Earnings per share, diluted-26.69-137.30-23.32-3.84-0.57-0.42-0.83-0.64-1.17-0.62

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents4.22M752.0K3.28M2.71M7.74M7.14M1.34M896.0K4.36M106.0K
Receivables289.0K98.0K318.0K9.00K200.0K25.0K111.0K95.0K24.0K6.00K
Inventory2.34M2.19M2.73M2.17M175.0K145.0K121.0K144.0K76.0K67.0K
Current assets7.27M3.33M6.49M5.61M8.34M7.97M1.84M1.23M4.52M221.0K
Property, plant and equipment119.0K9.00K7.00K7.00K5.00K4.00K4.00K8.00K5.00K11.0K
Goodwill29.1M
Total assets41.1M3.63M6.67M5.88M8.62M8.23M2.04M1.58M4.87M494.0K
Accounts payable719.0K47.0K138.0K66.0K87.0K144.0K129.0K193.0K168.0K82.0K
Current liabilities6.66M2.72M2.45M2.32M1.90M2.90M409.0K640.0K797.0K565.0K
Total liabilities7.63M3.00M2.69M2.65M2.31M5.83M688.0K1.12M
Shareholders' equity33.5M627.0K3.99M3.23M6.31M2.39M1.35M463.0K3.63M-2.50M
Shares outstanding1.10M37.9K186.0K1.64M1.40M21.2M4.20M3.80M3.94M2.63M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-9.37M-2.52M-3.60M-7.04M-4.37M-3.39M-3.87M-3.55M-2.18M-1.53M
Capital spending-60.0K-3.00K-1.00K-3.00K-3.00K-2.00K-8.00K-8.00K
Free cash flow-9.43M-2.52M-3.60M-7.04M-4.37M-3.39M-3.56M-1.54M
Cash from investing88.0K-3.00K-1.00K-3.00K-3.00K-2.00K-8.00K-8.00K
Cash from financing12.8M1.00K4.22M2.09M4.58M9.52M4.32M94.0K6.44M33.0K
Change in cash3.50M-2.53M570.0K-5.02M204.0K6.20M442.0K-3.46M4.25M-1.51M

Open Financials

Filings

FilingDateTypeFiled with
NT 10-Q · Late filing noticeNov 16, 2026Explanation requestSEC
8-K · Current reportOct 14, 2026Material contractSEC
EFFECT · Notice that a registration is effectiveSep 4, 2026Other filingsSEC
8-K · Current reportAug 31, 2026Current reportSEC
10-Q · Quarterly reportAug 17, 2026Quarterly reportSEC
NT 10-Q · Late filing noticeAug 14, 2026Explanation requestSEC
8-K · Current reportAug 14, 2026Meeting outcomeSEC
8-K · Current reportAug 12, 2026Material contractSEC
S-3 · Registration statementAug 10, 2026Offer documentSEC
DEF 14A · Proxy statementJul 24, 2026Meeting noticeSEC
Show 200 filings
FilingDateTypeFiled with
PRE 14A · Preliminary proxy statementJul 14, 2026Meeting noticeSEC
8-K · Current reportJul 14, 2026Management or board changeSEC
8-K · Current reportJul 10, 2026Current reportSEC
SCHEDULE 13D/A · Big-stake notice, amendedJun 22, 2026Big-stake noticeSEC
4 · Change in ownershipJun 22, 2026Insider tradeSEC
EFFECT · Notice that a registration is effectiveMay 29, 2026Other filingsSEC
424B3 · ProspectusMay 28, 2026Offer documentSEC
CORRESP · Letter to the SECMay 26, 2026Other filingsSEC
UPLOAD · Letter from the SECMay 26, 2026Other filingsSEC
S-3 · Registration statementMay 18, 2026Offer documentSEC
10-Q · Quarterly reportMay 18, 2026Quarterly reportSEC
NT 10-Q · Late filing noticeMay 15, 2026Explanation requestSEC
144 · Notice of proposed saleMay 13, 2026Other filingsSEC
4 · Change in ownershipApr 17, 2026Insider tradeSEC
SCHEDULE 13D/A · Big-stake notice, amendedApr 17, 2026Big-stake noticeSEC
10-K · Annual reportApr 15, 2026Annual reportSEC
NT 10-K · Late filing noticeMar 31, 2026Explanation requestSEC
SCHEDULE 13G/A · Big-stake notice, amendedMar 6, 2026Big-stake noticeSEC
3 · Initial statement of ownershipFeb 26, 2026Insider tradeSEC
3 · Initial statement of ownershipFeb 11, 2026Insider tradeSEC
4 · Change in ownershipFeb 11, 2026Insider tradeSEC
SCHEDULE 13D · Big-stake noticeFeb 11, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeFeb 6, 2026Big-stake noticeSEC
8-K · Current reportFeb 6, 2026Management or board changeSEC
3/A · Initial statement of ownership, amendedFeb 5, 2026Insider tradeSEC
4 · Change in ownershipFeb 4, 2026Insider tradeSEC
3 · Initial statement of ownershipFeb 4, 2026Insider tradeSEC
8-K · Current reportJan 30, 2026Material contractSEC
3 · Initial statement of ownershipJan 12, 2026Insider tradeSEC
8-K · Current reportDec 30, 2025Management or board changeSEC
3 · Initial statement of ownershipDec 29, 2025Insider tradeSEC
8-K · Current reportDec 23, 2025Management or board changeSEC
EFFECT · Notice that a registration is effectiveDec 19, 2025Other filingsSEC
3 · Initial statement of ownershipDec 18, 2025Insider tradeSEC
3 · Initial statement of ownershipDec 18, 2025Insider tradeSEC
424B3 · ProspectusDec 18, 2025Offer documentSEC
8-K · Current reportDec 12, 2025Current reportSEC
S-3/A · Registration statement, amendedDec 9, 2025Offer documentSEC
8-K · Current reportDec 5, 2025Management or board changeSEC
8-K · Current reportNov 19, 2025Current reportSEC
10-Q · Quarterly reportNov 14, 2025Quarterly reportSEC
ARS · Annual report to shareholdersNov 10, 2025Annual reportSEC
DEF 14A · Proxy statementNov 10, 2025Meeting noticeSEC
PRE 14A · Preliminary proxy statementOct 30, 2025Meeting noticeSEC
8-K · Current reportOct 30, 2025Management or board changeSEC
S-3/A · Registration statement, amendedOct 6, 2025Offer documentSEC
8-K · Current reportSep 17, 2025Material contractSEC
424B5 · ProspectusSep 17, 2025Offer documentSEC
S-3 · Registration statementSep 15, 2025Offer documentSEC
10-Q · Quarterly reportAug 19, 2025Quarterly reportSEC
8-K · Current reportAug 14, 2025Management or board changeSEC
NT 10-Q · Late filing noticeAug 14, 2025Explanation requestSEC
8-K · Current reportAug 8, 2025Current reportSEC
8-K · Current reportJul 30, 2025Management or board changeSEC
8-K · Current reportJul 22, 2025Material contractSEC
8-K · Current reportJul 18, 2025Meeting outcomeSEC
8-K · Current reportJul 11, 2025Current reportSEC
8-K · Current reportJul 9, 2025Current reportSEC
DEFA14A · Additional proxy materialJun 25, 2025Meeting noticeSEC
DEF 14A · Proxy statementJun 20, 2025Meeting noticeSEC
PRE 14A · Preliminary proxy statementJun 9, 2025Meeting noticeSEC
8-K · Current reportJun 4, 2025Management or board changeSEC
10-Q · Quarterly reportMay 20, 2025Quarterly reportSEC
SCHEDULE 13G · Big-stake noticeMay 19, 2025Big-stake noticeSEC
8-K · Current reportMay 16, 2025Material contractSEC
424B4 · ProspectusMay 16, 2025Offer documentSEC
NT 10-Q · Late filing noticeMay 15, 2025Explanation requestSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2025Big-stake noticeSEC
EFFECT · Notice that a registration is effectiveMay 15, 2025Other filingsSEC
CORRESP · Letter to the SECMay 14, 2025Other filingsSEC
CORRESP · Letter to the SECMay 14, 2025Other filingsSEC
S-1/A · Registration statement, amendedMay 14, 2025Offer documentSEC
S-1/A · Registration statement, amendedMay 12, 2025Offer documentSEC
S-1/A · Registration statement, amendedApr 29, 2025Offer documentSEC
S-1/A · Registration statement, amendedApr 22, 2025Offer documentSEC
8-K · Current reportApr 11, 2025Material contractSEC
8-K · Current reportApr 3, 2025Management or board changeSEC
10-K · Annual reportMar 31, 2025Annual reportSEC
8-K · Current reportMar 14, 2025Current reportSEC
8-K · Current reportMar 12, 2025Current reportSEC
8-K · Current reportFeb 25, 2025Meeting outcomeSEC
UPLOAD · Letter from the SECFeb 20, 2025Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 14, 2025Big-stake noticeSEC
S-1 · Registration statementFeb 14, 2025Offer documentSEC
8-K · Current reportFeb 14, 2025Acquisition or disposalSEC
DEF 14A · Proxy statementJan 27, 2025Meeting noticeSEC
PRE 14A · Preliminary proxy statementJan 16, 2025Meeting noticeSEC
8-K · Current reportJan 7, 2025FinancingSEC
8-K · Current reportJan 6, 2025Current reportSEC
4 · Change in ownershipJan 3, 2025Insider tradeSEC
4 · Change in ownershipJan 2, 2025Insider tradeSEC
4 · Change in ownershipJan 2, 2025Insider tradeSEC
4 · Change in ownershipJan 2, 2025Insider tradeSEC
4 · Change in ownershipJan 2, 2025Insider tradeSEC
4 · Change in ownershipJan 2, 2025Insider tradeSEC
4 · Change in ownershipJan 2, 2025Insider tradeSEC
4 · Change in ownershipJan 2, 2025Insider tradeSEC
4 · Change in ownershipJan 2, 2025Insider tradeSEC
8-K · Current reportDec 20, 2024Management or board changeSEC
8-K · Current reportDec 19, 2024Current reportSEC
8-K · Current reportDec 11, 2024Current reportSEC
8-K · Current reportNov 22, 2024Current reportSEC
SC 13G/A · Big-stake notice, amendedNov 14, 2024Big-stake noticeSEC
10-Q · Quarterly reportNov 14, 2024Quarterly reportSEC
ARS · Annual report to shareholdersOct 29, 2024Annual reportSEC
DEFA14A · Additional proxy materialOct 29, 2024Meeting noticeSEC
DEF 14A · Proxy statementOct 29, 2024Meeting noticeSEC
8-K · Current reportOct 11, 2024Current reportSEC
8-K · Current reportOct 7, 2024Current reportSEC
8-K · Current reportSep 25, 2024Management or board changeSEC
10-Q · Quarterly reportAug 14, 2024Quarterly reportSEC
8-K · Current reportMay 16, 2024Current reportSEC
10-Q · Quarterly reportMay 15, 2024Quarterly reportSEC
10-K/A · Annual report, amendedApr 26, 2024Annual reportSEC
8-K · Current reportApr 15, 2024Current reportSEC
10-K/A · Annual report, amendedApr 9, 2024Annual reportSEC
8-K · Current reportApr 9, 2024Current reportSEC
10-K · Annual reportApr 8, 2024Annual reportSEC
NT 10-K · Late filing noticeApr 1, 2024Explanation requestSEC
8-K · Current reportMar 28, 2024Material contractSEC
4 · Change in ownershipFeb 26, 2024Insider tradeSEC
4 · Change in ownershipFeb 26, 2024Insider tradeSEC
4 · Change in ownershipFeb 23, 2024Insider tradeSEC
4 · Change in ownershipFeb 23, 2024Insider tradeSEC
4 · Change in ownershipFeb 23, 2024Insider tradeSEC
4 · Change in ownershipFeb 23, 2024Insider tradeSEC
SC 13G · Big-stake noticeFeb 14, 2024Big-stake noticeSEC
DEFA14A · Additional proxy materialJan 17, 2024Meeting noticeSEC
8-K · Current reportJan 17, 2024Current reportSEC
8-K · Current reportDec 11, 2023Current reportSEC
4 · Change in ownershipDec 6, 2023Insider tradeSEC
4 · Change in ownershipDec 6, 2023Insider tradeSEC
4 · Change in ownershipDec 4, 2023Insider tradeSEC
4 · Change in ownershipDec 4, 2023Insider tradeSEC
4 · Change in ownershipDec 4, 2023Insider tradeSEC
4 · Change in ownershipDec 4, 2023Insider tradeSEC
4 · Change in ownershipDec 4, 2023Insider tradeSEC
4 · Change in ownershipDec 4, 2023Insider tradeSEC
4 · Change in ownershipDec 4, 2023Insider tradeSEC
8-K · Current reportDec 4, 2023Management or board changeSEC
DEFA14A · Additional proxy materialNov 29, 2023Meeting noticeSEC
DEF 14A · Proxy statementNov 29, 2023Meeting noticeSEC
8-K · Current reportNov 28, 2023Current reportSEC
8-K · Current reportNov 21, 2023Current reportSEC
8-K · Current reportNov 14, 2023Current reportSEC
10-Q · Quarterly reportNov 13, 2023Quarterly reportSEC
8-K · Current reportNov 7, 2023Current reportSEC
8-K · Current reportSep 27, 2023Current reportSEC
EFFECT · Notice that a registration is effectiveSep 22, 2023Other filingsSEC
424B3 · ProspectusSep 21, 2023Offer documentSEC
RW · Request to withdraw a registrationSep 21, 2023Other filingsSEC
CORRESP · Letter to the SECSep 19, 2023Other filingsSEC
UPLOAD · Letter from the SECSep 19, 2023Other filingsSEC
DSep 13, 2023Other filingsSEC
S-3 · Registration statementSep 12, 2023Offer documentSEC
8-K · Current reportSep 6, 2023Current reportSEC
8-K · Current reportSep 1, 2023Material contractSEC
8-K · Current reportAug 30, 2023Current reportSEC
8-K · Current reportAug 29, 2023Current reportSEC
8-K · Current reportAug 28, 2023Current reportSEC
8-K · Current reportAug 23, 2023Material contractSEC
EFFECT · Notice that a registration is effectiveAug 14, 2023Other filingsSEC
10-Q · Quarterly reportAug 11, 2023Quarterly reportSEC
CORRESP · Letter to the SECAug 9, 2023Other filingsSEC
UPLOAD · Letter from the SECAug 9, 2023Other filingsSEC
S-1/A · Registration statement, amendedAug 7, 2023Offer documentSEC
S-3 · Registration statementAug 1, 2023Offer documentSEC
8-K · Current reportJul 20, 2023Current reportSEC
S-1 · Registration statementJul 17, 2023Offer documentSEC
8-K · Current reportJun 21, 2023Meeting outcomeSEC
8-K · Current reportJun 14, 2023Current reportSEC
8-K · Current reportMay 25, 2023Current reportSEC
DEFA14A · Additional proxy materialMay 18, 2023Meeting noticeSEC
8-K · Current reportMay 18, 2023Current reportSEC
10-Q · Quarterly reportMay 15, 2023Quarterly reportSEC
ARS · Annual report to shareholdersMay 1, 2023Annual reportSEC
DEFA14A · Additional proxy materialMay 1, 2023Meeting noticeSEC
DEF 14A · Proxy statementMay 1, 2023Meeting noticeSEC
8-K · Current reportApr 19, 2023Current reportSEC
10-K · Annual reportApr 17, 2023Annual reportSEC
NT 10-K · Late filing noticeMar 31, 2023Explanation requestSEC
8-K · Current reportMar 28, 2023Current reportSEC
8-K · Current reportMar 21, 2023Current reportSEC
8-K · Current reportMar 14, 2023Current reportSEC
8-K · Current reportMar 3, 2023Current reportSEC
8-K · Current reportFeb 22, 2023Current reportSEC
8-K · Current reportFeb 8, 2023Current reportSEC
8-K · Current reportJan 18, 2023Current reportSEC
4 · Change in ownershipJan 5, 2023Insider tradeSEC
8-K · Current reportDec 15, 2022Management or board changeSEC

This page holds 200 of 552 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from ENvue Medical, Inc.’s releases · as of Aug 12, 2026

Common shares
923,717
Fully diluted
923,717

Fully diluted

LineShares
Common shares923,717

Share count over time

CountShares
Nov 22, 2026923,717
Aug 28, 2026

Open Cap table

Shareholders

Funds

HolderSharesOf the companyValueChangeAs of
Fidelity Extended Market Index Fund14,8280.13%US$13,375+7,054May 31, 2026
Fidelity Series Total Market Index Fund1,1880.01%US$1,072No changeMay 31, 2026
Vanguard Extended Market Index Fund189<0.01%US$97No changeJun 30, 2026

Big stakes

HolderStakeSharesDate
Glibert Christian Michael6.50%240KJan 14, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
David Johnson
Other companies: Firefly Neuroscience, Inc. (Executive Chairman, Director · Aug 19, 2024 – Oct 22, 2024 · Past); Enveric Biosciences, Inc. (CEO and Chairman, Director · Dec 30, 2020 – Feb 15, 2021 · Past); NexGel, Inc (Chief Executive Officer, Director · Jun 21, 2019 – Jun 21, 2019 · Past)
Chairman of the Board · Since at least Dec 4, 2025
Nicole Fernandez-McGovern
Other companies: MGO Global Inc. (Director · Jan 13, 2023 – Nov 28, 2023 · Past); AgEagle Aerial Systems, Inc. (Chief Financial Officer · Mar 26, 2018 – Sep 30, 2023 · Past)
CFO · Since at least Dec 18, 2025
Stephen Russell Brown
Other companies: Xsovt Brands, Inc. (EVP, CFO, Treas. and Secretary · Mar 1, 2011 – May 6, 2011 · Past); IDT Corporation (Chief Financial Officer · Jan 3, 2006 – Oct 29, 2008 · Past)
Chief Financial Officer · Apr 10, 2015 – Dec 30, 2024 · Past
Alison Geiger Burgett
Other companies: AgEagle Aerial Systems, Inc. (Chief Financial Officer · Since at least May 22, 2025)
Director · Since at least Dec 4, 2025
Harold Jacob
Other companies: Oramed Pharmaceuticals Inc. (Director · Aug 8, 2012 – Mar 10, 2016 · Past)
Chief Medical Officer, Director · Apr 10, 2015 – Dec 30, 2024 · Past
Michael Ferguson
Other companies: NeuBase Therapeutics Inc (Director · May 10, 2017 – May 12, 2017 · Past)
Director · Apr 27, 2015 – Dec 30, 2024 · Past
Anat HofshiVP Clinical Affairs & Product · Since at least Nov 4, 2026
Aurora CassirerDirector · Jan 13, 2022 – Dec 30, 2024 · Past
Brian M MurphyChief Executive Officer, Director · Oct 13, 2016 – Dec 30, 2024 · Past
Christopher M FashekDirector · Sep 29, 2020 – Dec 30, 2024 · Past
All 24 people
PersonSeat
Doron BesserChief Executive Officer and Director · Since at least Sep 15, 2026
Fred ReuningChief Marketing Officer · Since at least Nov 4, 2026
Jona ZumerisVP of Technology, Director · Apr 10, 2015 – Apr 10, 2015 · Past
Lior BuchmanDirector · Since at least Jul 15, 2026
Marc WaldmanVP Commercial · Since at least Jan 21, 2026
Maria SchroederDirector · Jan 13, 2022 – Dec 30, 2024 · Past
Martin M GoldsteinDirector · Apr 10, 2015 – Dec 30, 2024 · Past
Pellegrino PionatiDirector · Since at least Dec 4, 2025
Rita SilberbergSenior VP & Chief Accounting Officer · Since at least Nov 4, 2026
Thomas MikaDirector · Apr 27, 2015 – Dec 30, 2024 · Past
Tom DoldVP QA/RA · Since at least Nov 4, 2026
Zeev RotsteinDirector · Since at least Feb 14, 2025
Zenya GorlikVP R&D · Since at least Nov 4, 2026
Zvi JosephDirector · Since at least Jul 15, 2026

Open People

Log in to ask 6ix AI your own questions about ENvue Medical, Inc.